Table 2.
Secondary parameters to be included in WARN Pharmacokinetic Database, if available.
Patient characteristics | Antimalarial | Methodology | Pharmacokinetic parameters |
Height | Directly Observed Therapy (DOT) [1] | Method for separating free drug | Primary parameters: Absorption rate constant (Ka); Elimination Rate constant (Ke), Volume of distribution; Clearance rate. |
Vomiting | Batch number & Expiry Date | Sample handling | Secondary parameters: Cmax, tmax, elimination half-life; |
Diarrhoea | Method of Administration [2] | Total vs free drug | |
Baseline parasite density | Co-administration [3] | Metabolites | |
Haematocrit, Bilirubin, Creatinine, Albumin (alpha1 glycoprotein, lipoprotein) | |||
Ethnicity |
Footnotes to Table 2
DOT: All doses supervised; First dose supervised; Unsupervised.
2. Administration: Whole tablets; Divided tablets; Crushed tablets.
3. Co-administration: Water; Fat content; Sugar water; Concomitant medication